Mark Konijnenberg
Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
Kratochwil C, Fendler W, Eiber M, Hofman M, Emmett L, Calais J, Osborne J, Iravani A, Koo P, Lindenberg L, Baum R, Bozkurt M, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2023; 50:2830-2845.
29.05.2023Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
29.05.2023Eur J Nucl Med Mol Imaging 2023; 50:2830-2845
Kratochwil Clemens, Fendler Wolfgang Peter, Eiber Matthias, Hofman Michael S, Emmett Louise, Calais Jeremie, Osborne Joseph R, Iravani Amir, Koo Phillip, Lindenberg Liza, Baum Richard, Bozkurt Murat Fani, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Kabasakal Levent, Konijnenberg Mark, Kopka Klaus, Lassmann Michael, Mottaghy Felix M, Oyen Wim J G, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Hermann Ken
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Kratochwil C, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester H, Bodei L, Fanti S, Haberkorn U, Kopka K, Konijnenberg M, Kabasakal L, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Herrmann K. EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2019; 46:2536-2544.
22.08.2019EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
22.08.2019Eur J Nucl Med Mol Imaging 2019; 46:2536-2544
Kratochwil Clemens, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Kopka Klaus, Konijnenberg Mark, Kabasakal Levant, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Herrmann Ken
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
Giammarile F, Luster M, Tennvall J, Borson-Chazot F, Konijnenberg M, Lambert B, Brans B, Kraeber-Bodere F, Forrer F, Flux G, Chiesa C, Bodei L, Therapy, Oncology and Dosimetry Committees. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 2011; 38:1393-406.
01.07.2011EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
01.07.2011Eur J Nucl Med Mol Imaging 2011; 38:1393-406
Giammarile Francesco, Luster Markus, Tennvall Jan, Borson-Chazot Françoise, Konijnenberg Mark, Lambert Bieke, Brans Boudewijn, Kraeber-Bodere Françoise, Forrer Flavio, Flux Glenn, Chiesa Carlo, Bodei Lisa, Therapy, Oncology and Dosimetry Committees
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Forrer F, de Herder W, van Lom K, de Jong M, Teunissen J, Bakker W, Konijnenberg M, Bernard B, Kooij P, Krenning E, Kwekkeboom D. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate. Eur J Nucl Med Mol Imaging 2009; 36:1138-46.
27.02.2009Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
27.02.2009Eur J Nucl Med Mol Imaging 2009; 36:1138-46
Forrer Flavio, de Herder Wouter W, van Lom Kirsten, de Jong Marion, Teunissen Jaap J M, Bakker Willem H, Konijnenberg Mark, Bernard Bert F, Kooij Peter P, Krenning Eric P, Kwekkeboom Dik J
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
Müller C, Forrer F, Bernard B, Melis M, Konijnenberg M, Krenning E, de Jong M. Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs. Cancer Biother Radiopharm 2007; 22:151-9.
01.02.2007Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
01.02.2007Cancer Biother Radiopharm 2007; 22:151-9
Müller Cristina, Forrer Flavio, Bernard Bert F, Melis Marleen, Konijnenberg Mark, Krenning Eric P, de Jong Marion